|

Foster® 200/6 pMDI (BDP/FF-200/6 µg) Clinical Trials

1 actively recruiting trial

Also known as: Foster®

Pipeline

Phase 4: 1

Top Sponsors

  • Chiesi Farmaceutici S.p.A.1

Indications

Other1 trial

BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.